| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.34B | 36.80B | 34.18B | 31.21B | 29.52B | 26.95B |
| Gross Profit | 27.33B | 27.04B | 24.93B | 22.53B | 21.48B | 19.73B |
| EBITDA | 13.42B | 13.17B | 6.47B | 7.16B | 6.32B | 10.33B |
| Net Income | 7.48B | 7.33B | 3.12B | 6.14B | 2.28B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 73.46B | 70.36B | 74.12B | 68.33B | 72.16B | 71.17B |
| Cash, Cash Equivalents and Short-Term Investments | 10.04B | 9.77B | 11.24B | 11.28B | 9.70B | 11.66B |
| Total Debt | 0.00 | 8.07B | 10.65B | 8.79B | 13.09B | 15.14B |
| Total Liabilities | 28.10B | 25.13B | 28.31B | 24.93B | 29.31B | 29.65B |
| Stockholders Equity | 44.86B | 44.75B | 45.44B | 43.16B | 40.19B | 38.85B |
Cash Flow | ||||||
| Free Cash Flow | 8.03B | 8.26B | 4.42B | 5.55B | 4.77B | 5.42B |
| Operating Cash Flow | 8.84B | 9.00B | 5.22B | 6.33B | 5.65B | 6.22B |
| Investing Cash Flow | -356.00M | -1.39B | -667.00M | 906.00M | 667.00M | -3.06B |
| Financing Cash Flow | -9.84B | -8.17B | -3.40B | -7.73B | -6.34B | -56.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €1.26B | 37.95 | 58.60% | 1.88% | 10.92% | 6.42% | |
69 Neutral | €169.88B | 22.11 | 17.25% | 1.13% | 6.24% | 30.65% | |
64 Neutral | €127.05M | 15.51 | 23.52% | 0.63% | 2.18% | -9.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | €708.47M | -4.16 | -26.06% | ― | 9.19% | -37.73% |